Remove tag contract-development
article thumbnail

ICER says bluebird bio’s $2.1m gene therapy is cost-effective

pharmaphorum

million price tag. ICER’s assessment is still at the draft stage and could be changed after an ongoing comment period, but will be welcomed by bluebird and other gene therapy developers as they try to set a price for their one-shot treatments that will be accepted by payers.

FDA 64
article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A roadmap for adopting New Science 

pharmaphorum

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. However, New Science is more expensive to develop. billion and $6.7

article thumbnail

The Covid cash cow – a look at the Covid vaccine sales figures

pharmaphorum

The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic. The market potential for any vaccine currently in trials is lower because the only markets really are the developing countries, which can’t pay the same prices.”.

Vaccines 137
article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

Unlike other contracts, a refund for Cablivi depends on individual clinical outcomes compared to more commonly used population-based outcomes. Over the last few years, as price tags for drugs have continuously increased, the popularity of risk sharing agreements has been increasing at a rate of 24% annual average growth.

article thumbnail

Pharmaceutical Procurement Strategies Overview

Viseven

Outlining contract terms. Climate change is another factor, potentially disrupting supplies and contributing to hefty price tags. For example, blockchain is actively used to monitor every step in the cold chain, from manufacturing to delivery, using smart contracts. Need a hand with software development?

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. compared to a 5.1%

Insurance 105